Yes, Gilead CEO Daniel O’Day is ready to ink some deals. No, you won’t see him sweat it

A bevy of an­a­lysts turned out for Gilead’s Q4 call Tues­day night look­ing for some of the old siz­zle about the fu­ture that used to ex­cite them in the past. What they got was a lec­ture on steady im­prove­ment, sound judg­ment and prop­er deal­mak­ing — along with a plate­ful of slight­ly dis­ap­point­ing num­bers that left more than a few feel­ing a bit de­flat­ed by the end.

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA